• Markets
  • icon
  • Companies
GSS · ASX

Genetic Signatures Ltd. (ASX:GSS)

AU$0.69

 -0.005 (-0.719%)
ASX:Live
12/04/2024 03:00:58 PM
HALO Ords GROWTH AUS Fakey Shakey - Short EMA 125 Breakup All-Consensus +1
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

GSS Overview

GSS Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About GSS

Telephone

Address

Description

Genetic Signatures Ltd. is a research company, which engages in the identification and commercialization of individual genetic signatures for the diagnosis of infectious diseases. It is also involved in the sale of associated products into the diagnostic and research marketplaces. Its products include the treatment for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. It operates in the following geographical segments: Asia Pacific, Europe, Middle East, and Africa (EMEA), and Americas. The company was founded by Robert J. Birrell, Christopher M. Abbott, and Geoffrey Grigg on February 15, 2001 and is headquartered in Newtown, Australia.

GSS Price Chart

Key Stats

Market Cap

AU$129.61M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.38 - 0.83

Trade Value (12mth)

AU$12,897.00

1 week

-0.72%

1 month

3.76%

YTD

70.37%

1 year

-12.79%

All time high

2.87168

Key Fundamentals

EPS 3 yr Growth

483.500%

EBITDA Margin

-102.50%

Operating Cashflow

-$12m

Free Cash Flow Return

-25.50%

ROIC

-28.80%

Interest Coverage

-17,365.00

Quick Ratio

4.50

Other Data

Shares on Issue (Fully Dilluted)

144m

HALO Sector

Next Company Report Date

28-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.08

GSS Announcements

Latest Announcements

Date Announcements

12 March 24

Becoming a substantial holder

×

Becoming a substantial holder

29 February 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

22 February 24

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

22 February 24

1H 24 Market Update

×

1H 24 Market Update

31 January 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

29 January 24

Change in substantial holding

×

Change in substantial holding

25 January 24

Application for quotation of securities - GSS

×

Application for quotation of securities - GSS

25 January 24

Change of Director's Interest Notice - N Samaras

×

Change of Director's Interest Notice - N Samaras

25 January 24

Change of Director's Interest Notice - J Melki

×

Change of Director's Interest Notice - J Melki

25 January 24

Change of Director's Interest Notice - T Radford

×

Change of Director's Interest Notice - T Radford

25 January 24

Change of Director's Interest Notice - C Waldron

×

Change of Director's Interest Notice - C Waldron

25 January 24

Change of Director's Interest Notice - S Chatonsky

×

Change of Director's Interest Notice - S Chatonsky

24 January 24

Successful completion of underwritten rights issue

×

Successful completion of underwritten rights issue

22 January 24

Change in substantial holding

×

Change in substantial holding

03 January 24

Change in substantial holding

×

Change in substantial holding

03 January 24

Change in substantial holding

×

Change in substantial holding

02 January 24

Genetic Signatures Rights Issue Offer Booklet

×

Genetic Signatures Rights Issue Offer Booklet

02 January 24

Rights Issue - Notification to Ineligible Shareholders

×

Rights Issue - Notification to Ineligible Shareholders

02 January 24

Rights Issue - Additional Payment Option For NZ Shareholders

×

Rights Issue - Additional Payment Option For NZ Shareholders

02 January 24

Change in substantial holding

×

Change in substantial holding

29 December 23

Genetic Signatures Successfully Completes Placement

×

Genetic Signatures Successfully Completes Placement

29 December 23

Application for quotation of securities - GSS

×

Application for quotation of securities - GSS

29 December 23

Cleansing Notice

×

Cleansing Notice

29 December 23

Notification regarding unquoted securities - GSS

×

Notification regarding unquoted securities - GSS

29 December 23

Notification of cessation of securities - GSS

×

Notification of cessation of securities - GSS

GSS Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.01 0.02 -0.10 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.01 0.02 -0.10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 175.0 74.0 -547.2 Lock Lock Lock
     PE X Lock Lock Lock Lock 149.0 44.3 N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 70.4 0.0 N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.04 0.04 -0.07 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.00 0.06 -0.10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 651.8 4.8 -263.7 Lock Lock Lock
     Yield % Lock Lock Lock Lock -0.3 4.8 -19.1 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.0 0.0 N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.35 0.38 0.29 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.34 0.37 0.25 Lock Lock Lock
     Growth % Lock Lock Lock Lock 6.4 8.2 -31.2 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 146 145 147 Lock Lock Lock
Basic m Lock Lock Lock Lock 143 143 147 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 28 35 17 Lock Lock Lock
     Growth % Lock Lock Lock Lock 151.1 25.2 -52.2 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 3 4 6 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 4 7 -13 Lock Lock Lock
     Growth % Lock Lock Lock Lock 280.5 68.9 -276.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 15.1 20.4 -75.2 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 85 80 175 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 3 5 -17 Lock Lock Lock
     Growth % Lock Lock Lock Lock 175.6 53.7 -478.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 10.5 12.9 -102.5 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 2 2 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 2 3 -19 Lock Lock Lock
     Growth % Lock Lock Lock Lock 132.2 90.6 -736.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 5.5 8.4 -111.5 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 2 3 -18 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 -4 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 2 3 -14 Lock Lock Lock
     Growth % Lock Lock Lock Lock 184.2 74.4 -558.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock 6.2 8.6 -83.0 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 4 10 -12 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 5 3 8 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -5 -3 -8 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 0 8 -14 Lock Lock Lock
     Growth % Lock Lock Lock Lock 96.1 1,866.8 -277.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.0 0.2 -0.8 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 30 37 16 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 54 60 49 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -30 -37 -16 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 5 5 6 Lock Lock Lock
Equity $m Lock Lock Lock Lock 49 55 43 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 49 55 43 Lock Lock Lock
     Growth % Lock Lock Lock Lock 6.6 10.9 -21.7 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 3.2 5.1 -28.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 3.6 5.6 -32.7 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 3.2 5.7 -38.7 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 3.7 5.9 -28.8 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 8.8 18.8 -25.5 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock 82.8 241.2 -17,365.0 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -10.0 -8.0 0.9 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -60.2 -67.3 -38.1 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 10.3 10.7 6.0 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 7.7 8.5 4.5 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 63.2 72.0 45.0 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 90.7 204.1 -205.2 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 4.3 7.5 2.2 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 2.5 2.5 3.1 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.7 0.8 0.6 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 9.7 9.6 22.3 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.5 0.6 0.3 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.5 0.6 0.3 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 6.2 8.6 -109.1 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 3.2 5.1 -37.6 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 3.2 5.1 -28.6 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.1 1.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 3.6 5.6 -32.7 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 3.6 5.6 -32.7 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 147.3 144.5 116.6 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 84.8 49.0 165.9 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 232.2 193.5 282.4 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 28.6 42.9 46.5 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 203.5 150.6 236.0 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.08%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

GSS Shortsell

Frequently Asked Questions

The current share price of Genetic Signatures Ltd. (GSS:ASX) is AU$0.69.
The 52-week high share price for Genetic Signatures Ltd. (GSS:ASX) is AU$0.83.
The 52-week low share price for Genetic Signatures Ltd. (GSS:ASX)? is AU$0.38.
Genetic Signatures Ltd. (GSS:ASX) does not pay a dividend.
Genetic Signatures Ltd. (GSS:ASX) does not pay a dividend.
Genetic Signatures Ltd. (GSS:ASX) has a franking level of 0%.
Genetic Signatures Ltd. (GSS:ASX) is classified in the Industrials.
The current P/E ratio for Genetic Signatures Ltd. (GSS:ASX) is .